In non-Sq NSCLC, CRC and endometrial cancer TP53 was the most frequently altered gene and tended to be mutually exclusive from KRAS, whereas TP53 alterations tended to co-occur with KRAS in PDAC. This evidence concerns the gene TP53 and non-small cell lung carcinoma.